Supernus Pharmaceuticals, Inc. (LON:0LB2)
33.87
-0.06 (-0.16%)
At close: Feb 21, 2025
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 652 employees as of December 31, 2023. The number of employees increased by 40 or 6.54% compared to the previous year.
Employees
652
Change (1Y)
40
Growth (1Y)
6.54%
Revenue / Employee
746.07K GBP
Profits / Employee
68.33K GBP
Market Cap
1.44B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Genus | 3,500 |
Supernus Pharmaceuticals News
- 11 days ago - Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 19 days ago - Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson's Disease - GlobeNewsWire
- 27 days ago - Supernus Pharmaceuticals Inc (SUPN) Announces FDA Approval for Updated Qelbree Label - GuruFocus
- 2 months ago - Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (viloxazine) in Canada - GlobeNewsWire
- 3 months ago - Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 3 months ago - Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference - GlobeNewsWire
- 3 months ago - Supernus Pharmaceuticals: Recently Launched Qelbree Is Powering Growth - Seeking Alpha
- 3 months ago - Supernus Pharmaceuticals, Inc. (SUPN) Q3 2024 Earnings Call Transcript - Seeking Alpha